Literature DB >> 7948023

Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages.

A Rempel1, P Bannasch, D Mayer.   

Abstract

The activity, intracellular distribution and mRNA expression of hexokinase isoenzymes were studied in normal rat liver, and in epithelial liver cells at different stages of neoplastic transformation, including non-tumorigenic and tumorigenic cell lines. In contrast to liver, all transformed cells exhibited only hexokinase I and II, which both showed significantly increased activity, hexokinase II being the more abundant form. In parallel, the mRNA expression of the two isoenzymes was elevated, indicating transcriptional control of gene expression. Hexokinase I and II were found in the cytosol and bound to mitochondrial membranes; the percentage of membrane-bound enzyme activity increased with the grade of transformation from 32% of total activity in normal liver up to 69% in dedifferentiated tumor cells. The ratio of hexokinase I/II was higher in the membrane fraction than in the cytosol. In all tissues studied hexokinase II could be resolved in two subtypes IIa and IIb by hydrophobic interaction chromatography. The relative proportion of cytosolic IIa and IIb varied significantly between normal liver (1:1) and transformed cells, and among cells of different transformation stages (4:1 to 1:10). IIa demonstrated the main activity in the more differentiated, IIb in the less differentiated cell lines. IIa-activity showed a good correlation with the intracellular glucose 6-phosphate concentration of the cells. The data indicate that neoplastic cell transformation is accompanied by progressive alterations in the proportion and subcellular distribution of hexokinase isoenzymes I and II.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948023     DOI: 10.1016/0167-4781(94)90225-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

Review 1.  Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.

Authors:  Saroj P Mathupala; Young H Ko; Peter L Pedersen
Journal:  Semin Cancer Biol       Date:  2008-12-03       Impact factor: 15.707

2.  Hexokinase II in CD133+ and CD133- hepatoma BEL-7402 Cells.

Authors:  Lei Gong; Zhuqingqing Cui; Xin Yu; Yuhua Wei; Jirun Peng; Xisheng Leng
Journal:  Pathol Oncol Res       Date:  2011-09-10       Impact factor: 3.201

3.  Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.

Authors:  Anna V Kudryavtseva; Maria S Fedorova; Alex Zhavoronkov; Alexey A Moskalev; Alexander S Zasedatelev; Alexey A Dmitriev; Asiya F Sadritdinova; Irina Y Karpova; Kirill M Nyushko; Dmitry V Kalinin; Nadezhda N Volchenko; Nataliya V Melnikova; Kseniya M Klimina; Dmitry V Sidorov; Anatoly Y Popov; Tatiana V Nasedkina; Andrey D Kaprin; Boris Y Alekseev; George S Krasnov; Anastasiya V Snezhkina
Journal:  BMC Genet       Date:  2016-12-22       Impact factor: 2.797

Review 4.  Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria.

Authors:  S P Mathupala; Y H Ko; P L Pedersen
Journal:  Oncogene       Date:  2006-08-07       Impact factor: 9.867

Review 5.  The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies.

Authors:  Saroj P Mathupala; Young H Ko; Peter L Pedersen
Journal:  Biochim Biophys Acta       Date:  2010-04-08

6.  Expression and role in glycolysis of human ADP-dependent glucokinase.

Authors:  Susan Richter; Jan P Richter; Sunali Y Mehta; Amanda M Gribble; Andrew J Sutherland-Smith; Kathryn M Stowell; Cristin G Print; Ron S Ronimus; William R Wilson
Journal:  Mol Cell Biochem       Date:  2012-01-05       Impact factor: 3.396

7.  The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model.

Authors:  Hwan Jun Jae; Jin Wook Chung; Hee Sun Park; Min Jong Lee; Ki Chang Lee; Hyo-Cheol Kim; Jung Hwan Yoon; Hesson Chung; Jae Hyung Park
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

8.  In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death.

Authors:  Heftsi Azoulay-Zohar; Adrian Israelson; Salah Abu-Hamad; Varda Shoshan-Barmatz
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

9.  The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death.

Authors:  Syed Mohammad Moin; Milena Panteva; Shahid Jameel
Journal:  J Biol Chem       Date:  2007-05-08       Impact factor: 5.157

10.  Mitochondrial and nuclear genes of mitochondrial components in cancer.

Authors:  E Kirches
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.